Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06610474 · ClinicalTrials.gov registry record · NA

Evaluation of an Online Prostate Cancer Screening Decision Aid

A NA study of Prostate Cancer, sponsored by David Siegel.

Recruiting
Registry status
NA
Development phase
510
Enrollment target
4
Study locations

NCT06610474 is a NA study of Prostate Cancer that is actively recruiting participants, run by David Siegel. The registered enrollment target is 510 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (16% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06610474, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by David Siegel.

RECRUITING
Registry status
NA
Development phase
510 participants
Enrollment target
4
Study locations

Study Summary

The goal of this clinical trial is to learn if the online, simulated human "Talk to Nathan About Prostate Cancer Screening" decision aid (https://www.cdc.gov/prostate-cancer/talk-to-nathan/index.html) is effective in helping patients decide about prostate cancer screening. The main questions it aims to answer are: * Is using the "Talk to Nathan About Prostate Cancer Screening" decision aid effective in improving knowledge, overcoming health literacy barriers, and resolving decisional conflict compared to a standard decision aid or standard education materials? * What are the barriers and best practices for incorporating Talk to Nathan About Prostate Cancer Screening into the flow of primary care practice? Researchers will compare "Talk to Nathan About Prostate Cancer Screening" to a standard decision aid and to standard prostate cancer screening education materials to test the effectiveness of using "Talk to Nathan About Prostate Cancer Screening." Participants will: * Use "Talk to Nathan About Prostate Cancer Screening," use a standard decision aid, or use standard education materials about prostate cancer screening * Visit the primary care clinic for follow-up * Complete surveys as part of the clinical trial

Conditions Studied

Prostate Cancer

Interventions

  • BEHAVIORAL Use of the online "Talk to Nathan about Prostate Cancer" decision aid
  • BEHAVIORAL Use of a standard prostate cancer screening decision aid
  • BEHAVIORAL Use of standard prostate cancer education materials

Study Locations (4)

North Carolina

  • Camino - Charlotte
  • Alliance Medical Ministry - Raleigh

New York

  • East Northport Medical Care - East Northport

South Carolina

  • Clemson Rural Health - Clemson

Trial Details

FieldValue
Enrollment Target 510 participants
Start Date 2024-11-27
Est. Completion 2026-01
Phase NA

Sponsor

David Siegel

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06610474

The ClinicalTrials.gov registry entry for NCT06610474 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 510 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (16% lower). The listed sponsor is David Siegel, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 3 interventions - of which Use of the online "Talk to Nathan about Prostate Cancer" decision aid is the first listed.

NCT06610474 reports 4 study locations spanning 3 distinct geographic areas - top geographies include North Carolina, New York, South Carolina.

Frequently Asked Questions

What is clinical trial NCT06610474 about?

NCT06610474 is a clinical study titled "Evaluation of an Online Prostate Cancer Screening Decision Aid". The goal of this clinical trial is to learn if the online, simulated human "Talk to Nathan About Prostate Cancer Screening" decision aid (https://www.cdc.gov/prostate-cancer/talk-to-nathan/index.html) is effective in helping patients decide about prostate cancer screening. The main questions it aims...

What is the current status of trial NCT06610474?

This trial is currently recruiting. It is a NA study. The enrollment target is 510 participants. The study started on 2024-11-27. Estimated completion is 2026-01.

What conditions does trial NCT06610474 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT06610474?

The interventions under investigation include: Use of the online "Talk to Nathan about Prostate Cancer" decision aid (BEHAVIORAL), Use of a standard prostate cancer screening decision aid (BEHAVIORAL), Use of standard prostate cancer education materials (BEHAVIORAL).

Who is sponsoring clinical trial NCT06610474?

This trial is sponsored by David Siegel, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06610474 being conducted?

This trial has 4 study locations across New York, North Carolina, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.